GS-441524 is a nucleoside analogue antiviral compound that has become an important reference in feline infectious peritonitis (FIP) management. As veterinary research and clinical experience continue to expand, oral tablet formulations have become a practical choice for long-term antiviral support in cats.
Unlike injectable products, oral tablets are easier to administer during daily treatment routines and may help reduce the stress associated with repeated injections. This makes them a suitable option for caregivers seeking a convenient method of administration while maintaining consistent treatment schedules.
Manufactured under controlled production conditions, GS-441524 tablets are produced with strict quality management procedures to ensure product consistency, stability, and reliable performance throughout storage and transportation.
The tablet formulation offers a convenient alternative to injectable products. Daily administration can be incorporated more easily into regular care routines, especially during extended treatment periods.
Each production batch is manufactured using standardized procedures and quality control systems to maintain consistency in appearance, composition, and overall product quality.
From raw material selection to finished packaging, every production stage follows established manufacturing standards. Batch identification allows complete traceability throughout the supply chain.
Many FIP management programs require continuous antiviral support over an extended period. The tablet formulation is designed to fit into long-term veterinary treatment plans while providing convenient handling for caregivers.
The product is suitable for room-temperature storage under recommended conditions, making transportation, inventory management, and daily use more convenient.
![]()
Feline infectious peritonitis is a serious viral disease that develops after feline coronavirus mutates within the body. Although feline coronavirus is common among cats, only a small number of infected animals develop FIP.
The disease may present in different clinical forms depending on the organs involved. Some cats develop fluid accumulation within the abdomen or chest, while others experience inflammation affecting internal organs, the eyes, or the nervous system. Because the clinical presentation varies considerably, treatment plans should always be tailored to the individual patient.
Veterinary evaluation, regular observation, and ongoing monitoring play an important role throughout the treatment process.
GS-441524 tablets are commonly supplied for professional veterinary use in a variety of environments, including:
The oral formulation is widely selected for situations where convenient daily administration is preferred during ongoing antiviral management.
For optimal product stability, the following storage conditions are recommended:
Proper storage helps preserve product integrity throughout its shelf life.
![]()
Each batch is produced under standardized manufacturing procedures with quality inspection performed throughout the production process. Batch records, labeling, and traceability systems support consistent product management from manufacturing to delivery.
The product is packaged securely to help maintain quality during transportation and international shipment.
This product is intended for veterinary use only.
Treatment protocols, dosage schedules, and administration methods should be determined by qualified veterinary professionals based on the cat's clinical condition and ongoing evaluation.